Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
about
Recent Advances in the Neoadjuvant Treatment of Breast Cancer.A Systems Biology Approach Provides Deeper Insights into Differentially Expressed Genes in Taxane-Anthracycline Chemoresistant and Non-Resistant Breast CancersSynchrotron microtomography to evaluate effects of different polychemotherapy drugs on cortical bone structure.Clinical and Molecular Methods in Drug Development: Neoadjuvant Systemic Therapy in Breast Cancer as a Model.
P2860
Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Anthracyclines and taxanes in ...... cer: does the sequence matter?
@en
type
label
Anthracyclines and taxanes in ...... cer: does the sequence matter?
@en
prefLabel
Anthracyclines and taxanes in ...... cer: does the sequence matter?
@en
P2093
P2860
P356
P1433
P1476
Anthracyclines and taxanes in ...... cer: does the sequence matter?
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDU007
P50
P577
2014-03-13T00:00:00Z